Xavier Fradera

12PUBLICATIONS
43CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsBiologically active moleculesBiomolecular modelling and designProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.

Chunhui Huang, Christian Fischer, Michelle R Machacek

|Mar 03, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.

Derun Li, David L Sloman, Abdelghani Achab

|Feb 01, 2022
NMR Data-Driven Docking of HDM2-Inhibitor Complexes.

Xavier Fradera, Michael H Reutershan, Michelle R Machacek

|Oct 29, 2021
Discovery of MK-4688: an Efficient Inhibitor of the HDM2-p53 Protein-Protein Interaction.

Michael H Reutershan, Michelle R Machacek, Michael D Altman

|Sep 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors.

Brett Hopkins, Hongjun Zhang, Indu Bharathan

Pageof 2